(Q34519154)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

2 August 2017

0 references

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. (English)

1 reference

2 August 2017

0 references

0 references

2

1 reference

2 August 2017

Bruno R da Costa

1

0 references

Sven Trelle

object named as

Sven Trelle

7

0 references

Peter Jüni

6

object named as

Peter Jüni

1 reference

2 August 2017

Noah Keller

3

1 reference

2 August 2017

Linda Nartey

4

1 reference

2 August 2017

Simon Wandel

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

17 March 2016

1 reference

2 August 2017

1 reference

2 August 2017

387

1 reference

2 August 2017

10033

1 reference

2 August 2017

2093-2105

1 reference

Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Problems and needs for improving primary care of osteoarthritis patients: the views of patients, general practitioners and practice nurses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Primary care treatment of knee pain--a survey in older adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Osteoarthritis: rational approach to treating the individual

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Use and costs of prescription medications and alternative treatments in patients with osteoarthritis and chronic low back pain in community-based settings.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Patterns of therapy switching, augmentation, and discontinuation after initiation of treatment with select medications in patients with osteoarthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Management pattern for patients with osteoarthritis treated with traditional non-steroidal anti-inflammatory drugs in Spain prior to introduction of Coxibs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Evaluation of patients' and physicians' expectations and attributes of osteoarthritis treatment using Kano methodology.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

OARSI guidelines for the non-surgical management of knee osteoarthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta-analysis of randomised placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Borrowing strength from external trials in a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Meta-analysis: chondroitin for osteoarthritis of the knee or hip.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Bayesian approaches to random-effects meta-analysis: a comparative study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Combination of direct and indirect evidence in mixed treatment comparisons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Mixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Variance imputation for overviews of clinical trials with continuous response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Checking consistency in mixed treatment comparison meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Graphical tools for network meta-analysis in STATA.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Non-steroidal anti-inflammatory drugs for the treatment of pain and immobility-associated osteoarthritis: consensus guidance for primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Potentially inappropriate prescribing and cost outcomes for older people: a national population study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

NIH mulls rules for validating key results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Replication of multicenter clinical trials for efficacy?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Clinical pharmacology of novel selective COX-2 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930002-2

7 January 2021

10.1016/S0140-6736(16)30002-2

Identifiers

DOI

1 reference

2 August 2017

1 reference